These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17403383)

  • 1. Von Willebrand disease presenting as recurrent hemorrhage after transvaginal oocyte retrieval.
    Moayeri SE; Coutre SE; Ramirez EJ; Westphal LM
    Am J Obstet Gynecol; 2007 Apr; 196(4):e10-1. PubMed ID: 17403383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Von Willebrand disease: a common and unrecognized bleeding disorder].
    Boehlen F; Robert-Ebadi H; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of hemorrhage and elimination of immune inhibitors in a female patient with a severe form of von Willebrand's disease.
    Marisavljević D; Elezović I; Miljić P; Radulović M; Stajić M
    Srp Arh Celok Lek; 1997; 125(9-10):311-6. PubMed ID: 9340805
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal uterine bleeding and underlying hemostatic disorders: report of a consensus process.
    Munro MG; Lukes AS;
    Fertil Steril; 2005 Nov; 84(5):1335-7. PubMed ID: 16275226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel.
    James AH; Kouides PA; Abdul-Kadir R; Edlund M; Federici AB; Halimeh S; Kamphuisen PW; Konkle BA; Martínez-Perez O; McLintock C; Peyvandi F; Winikoff R
    Am J Obstet Gynecol; 2009 Jul; 201(1):12.e1-8. PubMed ID: 19481722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Patient with recurrent gastrointestinal hemorrhage in acquired von Willebrand disease].
    Baerlocher GM; Leoncini-Franscini L; Wuillemin WA; Furlan M
    Ther Umsch; 1999 Sep; 56(9):487-90. PubMed ID: 10517115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemorrhaging at menarche: a case report.
    Ward CL
    J Fam Pract; 1992 Mar; 34(3):351-4. PubMed ID: 1541960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic dilemma: dual presentations of clinical mucosal bleeding and venous thrombosis associated with the presence of thrombophilia markers and mild reduction in von Willebrand factor.
    Favaloro EJ; Bonar R; Survela L; McDonald D; Koutts J; Sioufi J; Marsden K
    Lab Hematol; 2007; 13(4):128-34. PubMed ID: 18192144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the significance of marginally low von Willebrand factor.
    Onundarson PT; Gudmundsdottir BR; Marder VJ
    Thromb Haemost; 2008 Dec; 100(6):1213-4. PubMed ID: 19132256
    [No Abstract]   [Full Text] [Related]  

  • 11. Prepubertal Bleeding as a Presenting Symptom of Von Willebrand Disease: A Case Report.
    Chambers C; Adeyemi-Fowode O
    J Pediatr Adolesc Gynecol; 2020 Apr; 33(2):167-169. PubMed ID: 31883461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus complicated by acquired von Willebrand's syndrome.
    Hong S; Lee J; Chi H; Lee C; Nah S; Kim Y; Oh J; Moon H; Yoo B
    Lupus; 2008 Sep; 17(9):846-8. PubMed ID: 18755868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late postpartum hemorrhage due to von Willebrand disease managed with uterine artery embolization.
    Salman MC; Cil B; Esin S; Deren O
    Obstet Gynecol; 2008 Feb; 111(2 Pt 2):573-5. PubMed ID: 18239026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful prophylactic regimens for transvaginal oocyte retrieval in women with bleeding diatheses.
    Peavey M; Steward R; Paulyson-Nunez K; James A
    Haemophilia; 2013 May; 19(3):e189-91. PubMed ID: 23600910
    [No Abstract]   [Full Text] [Related]  

  • 16. [Urgent hemostatic control with Confact F for ovarian bleeding complicated by an unknown type of von Willebrand disease].
    Suzuki T; Kagawa K; Oishi T; Kawata K; Fujito A; Isaka K; Fukutake K
    Rinsho Ketsueki; 2008 Dec; 49(12):1623-7. PubMed ID: 19110525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Von Willebrand disease and menorrhagia].
    Touré FA; Kane GM; Diop S; Ndiaye DT; Diao H; Diouf L; Diaw G; Thiam D; Moreau JC; Diakhaté L
    Dakar Med; 2007; 52(2):100-5. PubMed ID: 19102102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of von Willebrand disease: new perspectives and nuances.
    Kessler CM
    Haemophilia; 2007 Dec; 13 Suppl 5():3-14. PubMed ID: 18078392
    [No Abstract]   [Full Text] [Related]  

  • 19. The Prevalence of von Willebrand disease in women with abnormal uterine bleeding.
    Goodman-Gruen D; Hollenbach K
    J Womens Health Gend Based Med; 2001 Sep; 10(7):677-80. PubMed ID: 11571097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease.
    Franchini M; Montagnana M; Lippi G
    Int J Lab Hematol; 2008 Apr; 30(2):91-4. PubMed ID: 18333841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.